Overview: Glucose Challenge Obstetric TestIntroduction: The Glucose Challenge Obstetric Test measures glucose 1 hour after a load to screen for gestational diabetes during pregnancy, preventing complications. Aligned with 2023 ACOG guidelines, it uses spectrophotometry for high sensitivity, aiding in pregnancy screening. This test is critical for early detection, management, and improving outcomes in biochemistry for pregnant patients. It is a preliminary screening tool to identify those needing further diagnostic testing.
Other Names: GCT Obstetrical Assay, 1-Hour Glucose Challenge Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Glucose challenge testing for pregnancy began in the 1970s. The 1-hour GCT was standardized in the 1980s, with spectrophotometry refinements in the 1990s.
Purpose: Screens for gestational diabetes, guides further testing, and monitors glucose levels in pregnant patients to prevent fetal complications.
Test Parameters: 1. Glucose (1 H Obstetrical)
Pretest Condition: Fasting for 10-12 hours required. Collect plasma or serum 1 hour after a glucose load (typically 50g). Report symptoms like fatigue or thirst, and list medications.
Specimen: 2-4 mL plasma (NaF) or 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fatigue, thirst, or history of gestational diabetes. Include pregnancy stage, current medications, and family history of diabetes.
Consent: Written consent required, detailing the tests purpose, screening implications, and potential need for further diagnostic testing.
Procedural Considerations: Uses spectrophotometry to measure glucose levels 1 hour post-glucose load. Results are available in 1-2 days, enabling rapid clinical decisions. Performed in laboratories, often as a first step in gestational diabetes screening.
Factors Affecting Result Accuracy: Non-fasting, improper timing, hemolysis, or medications (e.g., corticosteroids) can affect results. Patient stress may alter glucose levels.
Clinical Significance: Elevated glucose levels suggest a need for confirmatory OGTT to diagnose gestational diabetes. Normal levels may indicate low risk, but clinical correlation is needed.
Specialist Consultation: Consult an obstetrician or endocrinologist for result interpretation and further testing recommendations.
Additional Supporting Tests: 3-hour OGTT, HbA1c, fasting glucose, or ultrasound to confirm gestational diabetes and assess fetal health.
Test Limitations: As a screening test, it may yield false positives. Results require confirmatory testing for accurate diagnosis.
References: ACOG Gestational Diabetes Guidelines, 2023; Obstetrics & Gynecology, Metzger BE, 2022.
